Human Embryonic Stem Cell Cultivation: Historical Perspective and Evolution of Xeno-free Culture Systems

Overview

Journal Reprod Biol Endocrinol

Publisher Biomed Central

Specialties Endocrinology
Reproductive Medicine

Date 2015 Apr 19

PMID 25890180

Citations 39

Authors

Nina Desai

Pooja Rambhia

Arsela Gishto

Affiliations

Soon will be listed here.

Abstract

Human embryonic stem cells (hESC) have emerged as attractive candidates for cell-based therapies that are capable of restoring lost cell and tissue function. These unique cells are able to self-renew indefinitely and have the capacity to differentiate in to all three germ layers (ectoderm, endoderm and mesoderm). Harnessing the power of these pluripotent stem cells could potentially offer new therapeutic treatment options for a variety of medical conditions. Since the initial derivation of hESC lines in 1998, tremendous headway has been made in better understanding stem cell biology and culture requirements for maintenance of pluripotency. The approval of the first clinical trials of hESC cells for treatment of spinal cord injury and macular degeneration in 2010 marked the beginning of a new era in regenerative medicine. Yet it was clearly recognized that the clinical utility of hESC transplantation was still limited by several challenges. One of the most immediate issues has been the exposure of stem cells to animal pathogens, during hESC derivation and during in vitro propagation. Initial culture protocols used co-culture with inactivated mouse fibroblast feeder (MEF) or human feeder layers with fetal bovine serum or alternatively serum replacement proteins to support stem cell proliferation. Most hESC lines currently in use have been exposed to animal products, thus carrying the risk of xeno-transmitted infections and immune reaction. This mini review provides a historic perspective on human embryonic stem cell culture and the evolution of new culture models. We highlight the challenges and advances being made towards the development of xeno-free culture systems suitable for therapeutic applications.

Citing Articles

Revolutionized attitude toward recurrent pregnancy loss and recurrent implantation failure based on precision regenerative medicine.

Motlagh Asghari K, Novinbahador T, Mehdizadeh A, Zolfaghari M, Yousefi M Heliyon. 2024; 10(20):e39584.

PMID: 39498089 PMC: 11532865. DOI: 10.1016/j.heliyon.2024.e39584.

Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials.

Skoracka J, Bajewska K, Kulawik M, Suchorska W, Kulcenty K EXCLI J. 2024; 23:1170-1182.

PMID: 39391058 PMC: 11464958. DOI: 10.17179/excli2024-7088.

Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks.

Cucinella G, Gullo G, Catania E, Perino A, Billone V, Marinelli S J Pers Med. 2024; 14(2).

PMID: 38392569 PMC: 10890184. DOI: 10.3390/jpm14020135.

Xeno-free generation of new Yazd human embryonic stem cell lines (Yazd4-7) as a prior stage toward good manufacturing practice of clinical-grade raw materials from discarded embryos: A lab resources report.

Hajizadeh-Tafti F, Golzadeh J, Akyash F, Tahajjodi S, Farashahi-Yazd E, Heidarian-Meimandi H Int J Reprod Biomed. 2023; 21(8):619-628.

PMID: 37885973 PMC: 10598466. DOI: 10.18502/ijrm.v21i8.14017.

Current Progress in Stem Cell Therapy for Male Infertility.

Adriansyah R, Margiana R, Supardi S, Narulita P Stem Cell Rev Rep. 2023; 19(7):2073-2093.

PMID: 37440145 DOI: 10.1007/s12015-023-10577-3.

References

Klimanskaya I, Chung Y, Becker S, Lu S, Lanza R . Human embryonic stem cell lines derived from single blastomeres. Nature. 2006; 444(7118):481-5. DOI: 10.1038/nature05142. View

Marinho P, Vareschini D, Gomes I, da Silveira Paulsen B, Furtado D, Castilho L . Xeno-free production of human embryonic stem cells in stirred microcarrier systems using a novel animal/human-component-free medium. Tissue Eng Part C Methods. 2012; 19(2):146-55. DOI: 10.1089/ten.TEC.2012.0141. View

Albano R, Groome N, Smith J . Activins are expressed in preimplantation mouse embryos and in ES and EC cells and are regulated on their differentiation. Development. 1993; 117(2):711-23. DOI: 10.1242/dev.117.2.711. View

Li L, Bennett S, Wang L . Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr. 2012; 6(1):59-70. PMC: 3364139. DOI: 10.4161/cam.19583. View

Kawase E . Efficient Expansion of Dissociated Human Pluripotent Stem Cells Using a Synthetic Substrate. Methods Mol Biol. 2014; 1307:61-9. DOI: 10.1007/7651_2014_82. View

Amit M, Laevsky I, Miropolsky Y, Shariki K, Peri M, Itskovitz-Eldor J . Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc. 2011; 6(5):572-9. DOI: 10.1038/nprot.2011.325. View

Lutolf M, Gilbert P, Blau H . Designing materials to direct stem-cell fate. Nature. 2009; 462(7272):433-41. PMC: 2908011. DOI: 10.1038/nature08602. View

Furue M, Na J, Jackson J, Okamoto T, Jones M, Baker D . Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A. 2008; 105(36):13409-14. PMC: 2522264. DOI: 10.1073/pnas.0806136105. View

Hentze H, Graichen R, Colman A . Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol. 2006; 25(1):24-32. DOI: 10.1016/j.tibtech.2006.10.010. View

10.

Cheng L, Hammond H, Ye Z, Zhan X, Dravid G . Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells. 2003; 21(2):131-42. DOI: 10.1634/stemcells.21-2-131. View

11.

Levenstein M, Ludwig T, Xu R, Llanas R, Vandenheuvel-Kramer K, Manning D . Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 2005; 24(3):568-74. PMC: 4615709. DOI: 10.1634/stemcells.2005-0247. View

12.

Li L, Wang S, Jezierski A, Moalim-Nour L, Mohib K, Parks R . A unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells. 2009; 28(2):247-57. DOI: 10.1002/stem.289. View

13.

Chen S, Choo A, Chin A, Oh S . TGF-beta2 allows pluripotent human embryonic stem cell proliferation on E6/E7 immortalized mouse embryonic fibroblasts. J Biotechnol. 2006; 122(3):341-61. DOI: 10.1016/j.jbiotec.2005.11.022. View

14.

Strauss S . Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol. 2010; 28(10):989-90. DOI: 10.1038/nbt1010-989. View

15.

Martin M, Muotri A, Gage F, Varki A . Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 2005; 11(2):228-32. DOI: 10.1038/nm1181. View

16.

Chung Y, Klimanskaya I, Becker S, Li T, Maserati M, Lu S . Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell. 2008; 2(2):113-7. DOI: 10.1016/j.stem.2007.12.013. View

17.

Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R . Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng. 2005; 91(6):688-98. DOI: 10.1002/bit.20536. View

18.

Meng G, Liu S, Li X, Krawetz R, Rancourt D . Derivation of human embryonic stem cell lines after blastocyst microsurgery. Biochem Cell Biol. 2010; 88(3):479-90. DOI: 10.1139/o09-188. View

19.

Serra M, Correia C, Malpique R, Brito C, Jensen J, Bjorquist P . Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One. 2011; 6(8):e23212. PMC: 3151290. DOI: 10.1371/journal.pone.0023212. View

20.

Park Y, Kim J, Lee S, Choi I, Park S, Lee S . Human feeder cells can support the undifferentiated growth of human and mouse embryonic stem cells using their own basic fibroblast growth factors. Stem Cells Dev. 2011; 20(11):1901-10. DOI: 10.1089/scd.2010.0496. View